About Author: Dr Manusrut is the Consultant for Ear Nose Throat (ENT) Head and Neck surgeon at Yashoda Hospitals, Hyderabad. He is an expert with advanced training in Cochlear Implantation and Ear surgery. One of the first and youngest Fellowship-trained Cochlear Implant Surgeons in India, he has experience of performing more than 1500 surgeries encompassing all subspecialties of Ear, Nose, Throat, and Head and neck diseases.
An Increased surge of Mucormycosis disease also known as ‘Black Fungus’ has been found in patients with COVID-19. The disease starts from the nose and sinus, then quickly spreads to the eyes and the brain. On an average, 50 percent of patients may not even survive despite being provided with the best treatment possible, if the fungus spreads to the brain, and then there is hardly any chance for the patient to survive. It used to be a rare disease, doctors attended to hardly one case a year, but now the circumstances have changed and ENT specialists are seeing an increased incidence of mucormycosis in patients with active COVID-19 or who have recovered from it. Most of the patients with Mucormycosis are diabetics and have a history of taking steroids for Covid treatment that raises their sugar levels.
Early signs and symptoms
The early signs and symptoms for Mucormycosis disease are like this:
One-sided severe headache and pain behind the eye.
Nasal stuffiness, discharge or occasional bleeding.
Eyes swelling, inability to open eyes, redness of eyes, double vision, loss of vision etc.
Ulceration or Blackish discolouration of the roof of the mouth (palate).
The disease quickly progresses to the brain causing drowsiness, facial paralysis, numbness of the face, stroke, one side paralysis and even death.